Cutaneous T-cell lymphoma, unspecified, spleen is a rare type of non-Hodgkin lymphoma characterized by the proliferation of T-cells in the skin and potentially affecting the spleen. This condition can lead to significant morbidity and requires accurate diagnosis and documentation for effective treatment and billing. The ICD-10 Code C84.A7 facilitates precise coding for clinical encounters, ensuring proper reimbursement and aiding in public health reporting.
ICD-10 Code C84.A7 represents Cutaneous T-cell lymphoma, unspecified, spleen, a malignancy of T-lymphocytes that primarily affects the skin but may involve the spleen. This code is used when the specific type of cutaneous T-cell lymphoma is not identified, allowing for appropriate documentation and billing in clinical settings. It is essential for healthcare providers to use this code when diagnosing patients with this condition to ensure accurate medical records and reimbursement.
Cutaneous T-cell lymphoma, unspecified, spleen is a hematological malignancy that arises from T-lymphocytes and primarily manifests in the skin. The condition can progress to involve systemic sites, including the spleen, necessitating prompt medical intervention. Early diagnosis is crucial for effective management and treatment.
ICD-10 Code C84.A7 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to Cutaneous T-cell lymphoma, unspecified, spleen. This code is relevant in both acute and chronic care settings, ensuring comprehensive documentation and continuity of care.
In SOAP notes, ICD-10 Code C84.A7 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Cutaneous T-cell lymphoma, unspecified, spleen. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Management of Cutaneous T-cell lymphoma, unspecified, spleen may require hospitalization for advanced treatment options. Treatment approaches are tailored to the patient's condition and may include systemic therapies.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.A7 is critical in medical billing, particularly in hospital and specialty care settings for Cutaneous T-cell lymphoma, unspecified, spleen.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push technique. |
| 99214 | Established patient office visit, moderate complexity. |
| 85025 | Complete blood count with automated differential. |
Common Questions About Using ICD-10 Code C84.A7 for Cutaneous T-cell lymphoma, unspecified, spleen
What are the common symptoms of Cutaneous T-cell lymphoma?
Common symptoms include skin lesions that may be itchy or painful, fatigue, and potential splenomegaly. Patients may also experience systemic symptoms such as weight loss.
How is Cutaneous T-cell lymphoma diagnosed?
Diagnosis typically involves a combination of clinical examination, skin biopsy, and imaging studies to assess for systemic involvement, including the spleen.
What treatment options are available for this condition?
Treatment may include topical therapies, systemic chemotherapy, and phototherapy, depending on the severity and extent of the disease.
Is Cutaneous T-cell lymphoma contagious?
No, Cutaneous T-cell lymphoma is not contagious. It is a malignancy of the immune system and does not spread from person to person.
Clinical Notes
SOAP notes
DAP notes
AI medical notes